- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Sustainable Track Record
Indian Pharmaceuticals & Biotech Sustainable Track Record
UPDATED Apr 21, 2024
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
19 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
539561 | ₹109.75 | 3.8% | 121.0% | ₹11.1b | n/a | PE20.9x | n/a | n/a | ||
CONCORDBIO | ₹1,583.40 | 3.1% | n/a | ₹165.6b | ₹1,596.80 | PE54.4x | E23.8% | 0% | ||
506820 | ₹5,217.85 | 0.5% | 65.6% | ₹130.4b | n/a | PE93.6x | n/a | 0.3% | ||
540737 | ₹620.70 | 3.1% | 102.3% | ₹8.0b | n/a | PE36.3x | n/a | 0.08% | ||
506260 | ₹240.80 | 7.1% | 173.9% | ₹12.1b | n/a | PE22.2x | n/a | 0.8% | ||
524632 | ₹86.40 | 8.2% | 335.9% | ₹3.8b | n/a | PE20.4x | n/a | 0.1% | ||
MANKIND | ₹2,340.40 | 3.2% | n/a | ₹937.5b | ₹2,184.17 | PE54.3x | E18.7% | n/a | ||
530477 | ₹146.75 | -1.0% | 83.3% | ₹4.6b | n/a | PE18.9x | n/a | 0.3% | ||
524558 | ₹7,625.30 | 7.3% | 284.3% | ₹97.8b | ₹8,300.00 | PE30.9x | E9.2% | 0.1% | ||
500420 | ₹2,590.70 | 2.8% | 59.8% | ₹876.8b | ₹2,728.41 | PE58.7x | E21.3% | 1.2% | ||
524742 | ₹1,334.60 | 2.9% | 103.4% | ₹101.4b | ₹1,579.33 | PE23.2x | E1.0% | 0.4% | ||
GLS | ₹839.55 | 6.1% | 80.1% | ₹102.9b | ₹859.00 | PE19.8x | E11.2% | 2.7% | ||
500660 | ₹1,948.10 | 2.4% | 55.4% | ₹330.0b | ₹2,141.25 | PE62.4x | E21.1% | 1.6% | ||
500488 | ₹26,261.45 | 0.3% | 16.6% | ₹558.0b | ₹27,670.43 | PE48.7x | E13.2% | 1.2% | ||
INNOVACAP | ₹471.55 | -2.9% | n/a | ₹27.0b | n/a | PE32.6x | n/a | n/a | ||
RPGLIFE | ₹1,520.10 | 1.2% | 87.8% | ₹25.1b | n/a | PE29.7x | n/a | 0.8% | ||
AJANTPHARM | ₹2,091.35 | -1.2% | 62.5% | ₹263.3b | ₹2,271.20 | PE35.8x | E18.0% | 1.7% | ||
BETA | ₹1,386.20 | 6.9% | 77.7% | ₹13.3b | n/a | PE38.3x | n/a | n/a | ||
531569 | ₹193.80 | 31.9% | 260.3% | ₹2.3b | n/a | PE38.4x | n/a | n/a |
Page 1 of 1